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Purpose: To compare clinical, angiographic, and optical coherence tomographic characteristics between eyes 
with acute Vogt-Koyanagi-Harada (VKH) disease and eyes with acute bilateral central serous chorioretinopa-
thy (CSC), and to demonstrate distinguishing features between the two diseases in confusing cases.
Methods: The medical records of 35 patients with VKH disease and 25 patients with bilateral CSC were retro-
spectively reviewed. Characteristics according to slit-lamp biomicroscopy, ophthalmoscopy, fundus photogra-
phy, fluorescein angiography, indocyanine green angiography, and spectral-domain optical coherence tomog-
raphy were compared between the two diseases. 
Results: Five of 35 patients (10 of 70 eyes, 14.3%) with VKH disease were initially misdiagnosed as CSC pa-
tients, and six of 25 patients (12 of 50 eyes, 24%) with bilateral CSC were initially misdiagnosed as patients 
with VKH disease. Pigment epithelial detachment in CSC and optic disc hyperemia in VKH disease show the 
highest positive predictive values of 100% for each disease. 
Conclusions: Optic disc hyperemia in VKH disease and pigment epithelial detachment in bilateral CSC are the 
most specific clinical manifestations of each disease at initial patient presentation.
Key Words: Central serous chorioretinopathy, Fluorescein angiography, Indocy anine green angiography, Opti-
cal coherence tomography, Vogt-Koyanagi-Harada disease
Vogt-Koyanagi-Harada (VKH) disease is characterized 
by bilateral granulomatous uveitis, and is often associated 
with exudative retinal detachment, and with extraocular 
manifestations such as meningismus, tinnitus, alopecia, 
and vitiligo [1]. Central serous chorioretinopathy (CSC) is 
characterized by serous detachment of the neurosensory 
retina associated with choroidal vascular hyperpermeabili-
ty [2,3]. VKH disease and CSC are considered to be com-
pletely different diseases with different pathophysiologies.
The acute stages of both diseases are sometimes con-
fused with one another, particularly when the diseases 
manifest bilateral lesions such as bilateral subretinal fluid, 
multifocal leakages on fluorescein angiography (FA), and 
bilateral thick choroid on enhanced depth imaging optical 
coherence tomography (OCT) [4-8]. Yang et al. [9] recently 
reported that 90 of 410 patients (22.0%) with VKH disease 
had been initially misdiagnosed as patients with CSC in 
other hospitals. Also, CSC may clinically mimic VKH dis-
ease, particularly in atypical cases with unusually large, 
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bilateral bullous exudative retinal detachment [10,11].
In VKH disease, early and aggressive treatment with 
corticosteroids, followed by slow tapering of treatment 
over three to six months, has shown favorable anatomical 
and visual results. Delayed diagnosis, which is defined as 
diagnosis more than one month after a patient’s first symp-
toms and signs of VKH, could cause the disease in its 
acute phase to evolve into chronic recurrent disease [12]. In 
CSC, on the other hand, in cases of high levels of endoge-
nous and exogenous corticosteroids, correction to normal 
levels of corticosteroids could lead to resolution of detach-
ment in 90% of cases [13]. Without adequate management 
of CSC, atrophy of photoreceptors in the fovea—a contrib-
uting factor to irreversible visual loss—could occur as ear-
ly as four months after the onset of symptoms [14,15].
The present study compares clinical, angiographic, and 
optical coherence tomographic characteristics between 
eyes with acute VKH disease and eyes with acute bilateral 
CSC. By reviewing confusing cases, we demonstrate spe-
cific features that are useful in distinguishing between the 
two diseases in instances of bilateral lesions.
Materials and Methods
This retrospective observational study was approved by 
the institutional review board of Yonsei University, Seoul, 
Korea. We included treatment-naive patients with acute 
VKH disease or acute bilateral CSC from June 2006 to 
October 2014. At presentation, all 60 patients underwent a 
comprehensive ophthalmic examination, including 
best-corrected visual acuity (BCVA), slit-lamp biomicros-
copy, ophthalmoscopy, fundus photography, and FA 
(HRA2; Heidelberg Engineering, Dossenheim, Germany). 
Indocyanine green angiography (ICGA) was performed on 
32 eyes (45.7%) with VKH disease, and on 28 eyes (56%) 
with bilateral CSC. Spectralis OCT ver. 1.5.12.0 (Heidel-
berg Engineering) was performed on 50 eyes (71.4%) with 
VKH disease, and on all eyes with bilateral CSC.
Diagnosis of VKH disease was based on the revised di-
agnostic criteria for VKH by an international committee 
for nomenclature in ophthalmology (2001) [16]. Diagnosis 
of CSC was made in instances of serous detachment of the 
neurosensory retina with typical fluorescein leakage pat-
terns [17]. Inflammatory cell reaction was determined by 
cells in the anterior chamber or the vitreous cavity with 
slit-lamp biomicroscopy. Optic disc hyperemia was deter-
mined by fundus photography. Choroidal vascular hyper-
permeability was defined as multifocal hyperfluorescences 
in the middle and late phases of ICGA [18]. Signs of hypo-
fluorescent dots were defined as multiple dark spots in late-
phase ICGA [19,20]. Measures of BCVA were converted to 
the logarithm of the minimum angle of resolution (log-
MAR) equivalents.
Subretinal fluid was defined as homogenous hyporeflec-
tive space between the neurosensory retina and retinal pig-
ment epithelium (RPE) of a patient on OCT. Pigment epi-
thelium detachment (PED) was defined as a dome-shaped 
elevation of RPE with hyporeflectivity, bound inferiorly by 
a Bruch’s membrane. Subretinal septa was defined as a 
highly reflective line, separated from the inner and outer 
segments of photoreceptors in attached areas of the retina 
[21]. RPE folds were defined by the presence of at least two 
sets of peaks and troughs of RPE [22]. OCT findings were 
evaluated by two independent readers (WBS and MKK), 
in blinded clinical diagnosis. 
The central macular thickness (CMT) of patient eyes 
was measured by OCT, and was defined as a mean retinal 
thickness of 1 mm at the center, as described in the Early 
Treatment Diabetic Retinopathy Study [23]. Choroidal 
thickness was measured by enhanced depth imaging OCT, 
which was performed by positioning the objective lens of 
the Spectralis OCT scanner close enough to invert the im-
age, as previously described [24]. Subfoveal choroidal 
thickness was defined as the vertical distance from the hy-
perreflective line of Bruch’s membrane at the fovea to the 
outermost hyperref lective line of the chorioscleral inter-
face, and was measured using the calipers provided by 
software from the Heidelberg Spectralis OCT. 
Statistical analyses 
A chi-square test was used for categorical analysis, and 
two-sample t-tests were used for analysis of continuous 
variables. Fisher’s exact tests and Mann-Whitney U-tests 
were used if the expected cell count was lower than five. 
Data were expressed as mean ± standard deviation. A 
p-value less than 0.05 was considered significant. All sta-
tistical analyses were performed with SPSS ver. 18.0 (SPSS 
Inc., Chicago, IL, USA).
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Results
Seventy eyes from 35 patients with acute VKH disease, 
and 50 eyes from 25 patients with acute bilateral CSC were 
included in this study. The mean patient age was 43.5 ± 10.7 
years (range, 21 to 62 years) in the VKH group, and 51.1 ± 
12.1 years (range, 32 to 84 years) in the CSC group (p = 0.027). 
The study population showed male predominance (68%) in the 
CSC group, whereas the VKH group was predominately fe-
male (62.9%) (p = 0.035). Among all 60 patients, headaches 
were a more frequent symptom in the VKH group (54.3%) 
than in the CSC group (8%) (p < 0.001). Tinnitus occurred 
more frequently among patients in the VKH group (25.7%), 
although the comparison was not significant (Table 1).
In a mean follow-up period of 26 ± 21 months among 
VKH patients, final measures of BCVA showed significant 
improvement from 0.81 ± 0.62 to 0.15 ± 0.20 logMAR (p < 
0.001). In bilateral CSC patients, however, final BCVA val-
ues did not show significant improvement (p = 0.066). Ini-
tial BCVA values were significantly worse in the VKH 
group (0.81 ± 0.62 logMAR) than in the bilateral CSC 
group (0.29 ± 0.34 logMAR) (p < 0.001), but there were no 
significant differences in the final BCVA values of either 
group. Inflammatory cells in the anterior chamber or vitre-
ous cavity were more frequently observed among patients 
in the VKH group (58 of 70 eyes, 82.9%) than in the CSC 
group (2 of 50 eyes, 4.0%) (p < 0.001). Optic disc hyper-
emia was observed in 54 of 70 eyes (77.1%) in the VKH 
group, whereas none of the eyes of CSC patients showed 
disc hyperemia. During late-phase FA, multifocal leakages 
were observed in 65.7% of patient eyes in the VKH group 
and 90% of patient eyes in the CSC group (p = 0.001), and 
disc leakage was more frequently observed in the VKH 
group (85.7%) than in the CSC group (2.0%). During late-
phase ICGA, choroidal vascular hyperpermeability was 
more frequently observed in the CSC group (89.3%), 
whereas hypofluorescent dots were more frequently ob-
served in the VKH group (93.8%) (Table 2, Fig. 1A-1F, 
Table 1. Baseline characteristics of patients with acute 
Vogt-Koyanagi-Harada disease and acute bilateral central se-
rous chorioretinopathy
Clinical 
manifestation
VKH
(n = 35)
Bilateral CSC 
(n = 25) p-value
Age (yr) 43.5 ± 10.7
  (range, 21-62)
51.1 ± 12.1
 (range, 32-84) 
 0.027
Male : female 13 : 22 17 : 8  0.035
Headache     19 (54.3)     2 (8.0) <0.001
Tinnitus       9 (25.7)     2 (8.0)  0.101
Follow-up 
(mon)
 26 ± 21 
 (range, 18-33) 
 30 ± 20 
(range, 1-72) 
 0.372
Values are presented as mean ± SD, number, or number (%) un-
less otherwise indicated.
VKH = Vogt-Koyanagi-Harada disease; CSC = central serous 
chorioretinopathy.
Table 2. Comparison of clinical, angiographic, and optical 
coherence tomographic features between eyes with acute 
Vogt-Koyanagi-Harada disease and eyes with acute bilateral 
central serous chorioretinopathy
Clinical manifestation VKH(n = 70 eyes)
CSC
(n = 50 eyes) p-value
Initial BCVA (logMAR) 0.81 ± 0.62 0.29 ± 0.34 <0.001
Final BCVA (logMAR) 0.15 ± 0.20 0.21 ± 0.30  0.605
Inflammatory cell 
reaction
58 (82.9) 2 (4.0) <0.001
Optic disc hyperemia 54 (77.10) 0 (0) <0.001
Angiographic features
Multifocal leakage 
on FA
46 (65.7) 45 (90)  0.001
Disc leakage on FA 60 (85.7)  1 (2.0) <0.001
Choroidal vascular 
hyperpermeability 
on ICGA
2 (6.2)  25 (89.3) <0.001
Hypofluorescent dots 
on ICGA
30 (93.8)  12 (42.9) <0.001
Optical coherence 
tomographic features
Subretinal fluid 43 (86.0)  47 (94.0)  0.318
Pigment epithelial 
detachment
0 (0) 30 (60) <0.001
Subretinal septa 27 (54)  2 (4.0) <0.001
Folds of RPE 27 (54) 1 (2.0) <0.001
Initial central 
macular thickness 
(μm)
590 ± 309 405 ± 158  0.005
Initial subfoveal 
choroidal thickness 
(μm)
628 ± 171 465 ± 105 <0.001
Values are presented as mean ± SD or number (%); ICGA was 
performed in 32 eyes with VKH disease, and 28 eyes with CSC; 
Optical coherence tomography was performed in 50 eyes with 
VKH disease, and all of the CSC eyes.
VKH = Vogt-Koyanagi-Harada disease; CSC = central serous 
chorioretinopathy; BCVA = best-corrected visual acuity; log-
MAR = logarithm of the minimum angle of resolution; FA = flu-
orescein angiography; ICGA = indocyanine green angiography; 
RPE = retinal pigment epithelium.
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Fig. 2A-2F).
In comparing OCT findings between the VKH and CSC 
groups, PED was more frequently observed in the CSC 
group (p < 0.001), but subretinal septa and RPE folds were 
more frequently observed in the VKH group (p < 0.001 
and p < 0.001, respectively) (Fig. 1G and 1H, Fig. 2G and 
2H). Mean CMT was 590 ± 309 μm in the VKH group and 
405 ± 158 μm in the CSC group, and the VKH group had 
significantly thicker measures of CMT (p = 0.005). Initial 
subfoveal choroidal thickness was not measurable in 24 of 
the 50 eyes of patients (48%) with VKH disease, because 
the choroidal layer at presentation was thicker than the 
depth range of the Spectralis OCT (approximately 1,000 
μm) [7]. Even after exception of the non-measurable cases 
in the eyes of VKH patients, the mean subfoveal choroidal 
thickness was 628 ± 309 μm in the VKH group and 465 ± 
Fig. 1. Representative case of acute Vogt-Koyanagi-Harada 
disease. (A,B) On fundus examination, bilateral serous submac-
ular fluids and hyperemic discs are observed. (C,D) Late-phase 
fluorescence angiography shows multiple hyperfluorescent spots 
around the discs, and disc hyperfluorescence in both eyes. (E,F) 
Indocyanine green angiography shows hyperf luorescent dark 
dots throughout posterior poles in both eyes. (G,H) Optical coher-
ence tomography reveals subretinal fluid with thickened choroids.
Fig. 2. Representative case of acute bilateral central serous cho-
rioretinopathy. (A,B) On fundus examination, bilateral serous 
submacular f luids are observed. (C,D) Late-phase f luorescence 
angiography shows multifocal hyperfluorescent dots throughout 
posterior poles in both eyes. (E,F) Late-phase indocyanine green 
angiography shows multifocal hyperf luorescence, suggesting 
choroidal vascular hyperpermeability. (G,H) Optical coherence 
tomography (OCT) reveals subretinal f luid and thickened cho-
roids. Additionally, OCT scans reveal pigment epithelial detach-
ments (yellow arrows), corresponding to black lines in (A) and (B).
A A
C C
E E
G G
B B
D D
F F
H H
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105 μm in the CSC group. Patients in the VKH group had 
significantly thicker measures of subfoveal choroids (p < 
0.001).
Five of 35 patients (10 of 70 eyes, 14.3%) with VKH dis-
ease were initially misdiagnosed as having CSC, because 
six eyes (60%) did not show inflammatory cell reactions, 
and eight eyes (80%) did not show subretinal septa or RPE 
folds on OCT. Additionally, six of 25 patients (12 of 50 
eyes, 24%) with bilateral CSC were initially misdiagnosed 
as having VKH disease, because three patients (50%) had 
headaches or tinnitus. Optic disc hyperemia was observed 
in 54 of 120 eyes, and all 54 of these eyes were finally di-
agnosed with VKH, showing a 100% positive predictive 
value of optic disc hyperemia for VKH. What is more, 
PED was observed in 30 of 120 eyes, and all 30 of these 
eyes were finally diagnosed with CSC, demonstrating the 
100% positive predictive value of PED in CSC. In analyz-
ing each clinical manifestation, optic disc hyperemia and 
disc leakage on FA showed the highest positive predictive 
values in VKH, and PED showed the highest positive pre-
dictive value in bilateral CSC.
Thirty-four of 35 patients (97%) with VKH were treated 
with systemic corticosteroid of more than 0.75 mg/kg, fol-
lowed by gradual tapering over three to six months. Subse-
quently, three patients progressed into a chronic recurrent 
stage of the disease. Among the patients with bilateral 
CSC, focal laser photocoagulation was performed as an 
initial treatment in 13 of 50 eyes (26%), photodynamic 
therapy was performed in six eyes (12%), anti-vascular en-
dothelial growth factor was administered in 22 eyes (44%), 
and five eyes (10%) were observed without treatment. Two 
patients with bilateral CSC received systemic steroid treat-
ment as an initial treatment because of incorrect diagnosis.
Discussion
This study compares clinical, angiographic, and optical 
coherence tomographic characteristics between eyes with 
acute VKH disease and eyes with acute bilateral CSC. 
Subsequently, we review initially-misdiagnosed VKH or 
CSC cases in order to identify specific features that facili-
tate distinction between the two diseases. Patients with 
VKH disease were misdiagnosed at presentation as having 
CSC in 14.3% of patients in this study, which is similar to 
the rate of misdiagnosis of 16.7% in previous reports [9]. 
Incorrect diagnoses sometimes occur when patients do not 
show inflammatory cell reactions on slit-lamp ophthalmos-
copy, and do not have typical subretinal septa or RPE folds 
on OCT. However, PED is a good distinguishing point, be-
cause PED is not observed in any cases of VKH disease 
herein. On the other hand, patients with bilateral CSC were 
initially misdiagnosed as having VKH disease in 24% of 
our patients, particularly when the patients manifested 
headaches or tinnitus. In this case, optic disc hyperemia 
and disc leakage on FA are good distinguishing points, be-
cause these manifestations are not shown in the eyes of 
any CSC patients in this study. 
Optic disc hyperemia and disc leakage on FA are fre-
quently observed in the eyes of patients VKH disease, but 
are not observed in the group of CSC patients in this study. 
Indeed, these signs are related to the pathophysiology of 
VKH disease as an inflammatory disease. Because the op-
tic disc is known to be an intraocular structure that is sen-
sitive to posterior segment inflammation, the acute stage of 
VKH disease shows optic disc changes, such as disc stain-
ing or disc leakage on FA [25]. On the other hand, PED is 
frequently observed in the group of patients with CSC, and 
is not observed in the patients with VKH disease in this 
study. This is related to the pathophysiology of CSC. In-
creased hydrostatic pressure in the choroids of CSC eyes 
causes detachment of the pigment epithelium (i.e., PED), 
and the subsequent breakdown of RPE tight junctions in-
duces subretinal fluid from this choroidal fluid [26]. There-
fore, in confusing cases, the observation of optic disc hy-
peremia or disc leakages on FA in VKH disease, and PED 
on OCT in CSC could be helpful in making an accurate 
distinction between the two diseases.
Although inf lammatory cell reactions and subretinal 
septa or RPE folds on OCT were frequently observed in 
patients with VKH disease herein, these manifestations 
are not always observed in patients VKH disease. There-
fore, we cannot rule out VKH disease when patients do not 
manifest inf lammatory cells. In addition, because head-
aches and tinnitus are nonspecific symptoms, these symp-
toms alone cannot confirm VKH disease.
Without prompt and adequate corticosteroid treatment 
for patients with VKH, inflammation of the posterior seg-
ment may progress into anterior uveitis, and in turn, the 
anterior uveitis may proceed to recurrent or chronic gran-
ulomatous uveitis in VKH patients [9,27]. In CSC eyes, 
however, the use of corticosteroid potentially leads to ex-
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acerbation of the disease, and may result in permanent vi-
sual loss due to subretinal fibrosis and macular scar forma-
tion [11,28-30]. Accordingly, correct diagnosis of each 
disease at the initial presentation of patients is essential to 
improve the visual outcomes of patients with VKH or 
CSC. 
This study compares clinical, angiographic, and optical 
coherence tomographic characteristics between eyes with 
acute VKH disease and eyes with acute bilateral CSC. In 
conclusion, optic disc hyperemia in VKH disease and PED 
in bilateral CSC are the most specific clinical manifesta-
tions of each disease at initial patient presentation.
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